Published in Aliment Pharmacol Ther on May 01, 2003
Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients. World J Gastroenterol (2005) 0.89
Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial. World J Gastroenterol (2005) 0.79
Replacement of clarithromycin with azithromycin in triple therapy regimens for the eradication of Helicobacter pylori: A randomized clinical trial. J Med Life (2014) 0.76
The Helicobacter pylori eradication in the group receiving standard -dose and group continue taking amoxicillin for 4 weeks; a clinical trial study. Gastroenterol Hepatol Bed Bench (2015) 0.75
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A (2001) 7.99
Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology (1992) 4.19
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol (1999) 3.47
Immunodeficiency presenting as hypergammaglobulinaemia with IgG2 subclass deficiency. Lancet (1992) 3.45
Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr (2000) 3.35
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78
Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract (1998) 2.63
Allelic diversity and recombination in Campylobacter jejuni. J Bacteriol (2001) 2.61
Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology (1982) 2.50
A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut (1997) 2.32
CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer (2008) 2.23
Antibody response of patients against a 120 kDa surface protein of Campylobacter pylori. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 2.18
Hydrolysed cow's milk formulae. Allergenicity and use in treatment and prevention. An ESPACI position paper. European Society of Pediatric Allergy and Clinical Immunology. Pediatr Allergy Immunol (1993) 2.17
Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report. Allergy (2008) 2.12
Effects of a few food diet in attention deficit disorder. Arch Dis Child (1993) 2.12
Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J Clin Pathol (1981) 2.11
Comment on antigen-reduced infant formulae. ESPGAN Committee on Nutrition. Acta Paediatr (1993) 2.04
Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology (1983) 1.99
Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem (2000) 1.97
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91
Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res (2001) 1.83
Characterization of pili associated with Escherichia coli O18ac. Infect Immun (1980) 1.80
Purification of Helicobacter pylori superoxide dismutase and cloning and sequencing of the gene. Infect Immun (1993) 1.78
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study. Aliment Pharmacol Ther (2011) 1.76
The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol (2001) 1.73
Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun (1998) 1.67
Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology (1996) 1.67
Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol (2000) 1.66
Regulation of ferritin-mediated cytoplasmic iron storage by the ferric uptake regulator homolog (Fur) of Helicobacter pylori. J Bacteriol (2000) 1.66
Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg (1993) 1.62
Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut (2000) 1.62
Immune responses to fed protein antigens in mice. 3. Systemic tolerance or priming is related to age at which antigen is first encountered. Pediatr Res (1984) 1.60
Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab Invest (1990) 1.60
Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr (1995) 1.59
Nickel-responsive induction of urease expression in Helicobacter pylori is mediated at the transcriptional level. Infect Immun (2001) 1.59
Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation. Infect Immun (1998) 1.58
Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest. Digestion (2004) 1.57
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57
Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA (2001) 1.53
Identification and analysis of a new vacA genotype variant of Helicobacter pylori in different patient groups in Germany. J Clin Microbiol (1998) 1.51
Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of the jejunum. Gut (1984) 1.49
Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients. Am J Gastroenterol (1997) 1.48
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47
Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer (2011) 1.46
Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Microbiol Infect Dis (2000) 1.45
Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis--results from the EXPO study. Aliment Pharmacol Ther (2009) 1.44
Bacterial genetic fingerprint: a reliable factor in the study of the epidemiology of human campylobacter enteritis? J Clin Microbiol (2001) 1.44
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther (2003) 1.40
Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis. Arthritis Rheum (2000) 1.40
[Bleeding peptic ulcers--how can recurrent bleeding be prevented?]. Leber Magen Darm (1995) 1.37
Folding of maltose-binding protein. Evidence for the identity of the rate-determining step in vivo and in vitro. J Biol Chem (1993) 1.37
Serodiagnosis of Helicobacter pylori infections with an enzyme immunoassay using the chromatographically purified 120 kilodalton protein. Eur J Clin Microbiol Infect Dis (1992) 1.35
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). World J Gastroenterol (2001) 1.35
Isolation of Helicobacter pullorum from patients with enteritis. Scand J Infect Dis (1997) 1.34
Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol (2001) 1.32
Heterogeneity among Whipple's-disease-associated bacteria. Lancet (1994) 1.28
The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology (1998) 1.26
Molecular analysis of riboflavin synthesis genes in Bartonella henselae and use of the ribC gene for differentiation of Bartonella species by PCR. J Clin Microbiol (1999) 1.26
Cytogenetic analysis of 750 spontaneous abortions with the direct-preparation method of chorionic villi and its implications for studying genetic causes of pregnancy wastage. Am J Hum Genet (1990) 1.25
Negative regulation of CD4 expression in T cells by the transcriptional repressor ZEB. Int Immunol (1999) 1.24
Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest (1988) 1.21
Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer. Dis Colon Rectum (1998) 1.20
Late pulmonary metastasis in uterine PEComa. J Clin Pathol (2003) 1.20
The generation of a 'tolerogen' after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin Exp Immunol (1990) 1.19
A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. J Immunol (1997) 1.17
Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin Exp Allergy (2005) 1.17
Epidemiology of Whipple's disease in Germany. Analysis of 110 patients diagnosed in 1965-95. Scand J Gastroenterol (1997) 1.16
Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm. J Pathol (1999) 1.14
Cloning and characterization of the fur gene from Helicobacter pylori. FEMS Microbiol Lett (1998) 1.14
Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut (1997) 1.13
The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus. Horm Metab Res (2002) 1.13
Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Euro Surveill (2008) 1.12
One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther (1996) 1.12
Identification of iron-regulated genes of Helicobacter pylori by a modified fur titration assay (FURTA-Hp). FEMS Microbiol Lett (2000) 1.12
Structural, functional and mutational analysis of the pfr gene encoding a ferritin from Helicobacter pylori. Microbiology (1998) 1.11
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Aliment Pharmacol Ther (2002) 1.10
Antigastric autoantibodies in Helicobacter pylori gastritis: prevalence, in-situ binding sites and clues for clinical relevance. Virchows Arch (1996) 1.10
Helicobacter pylori induces apoptosis in gastric mucosa through an upregulation of Bax expression in humans. Scand J Gastroenterol (1999) 1.10
Prognosis of chronic granulomatous disease. Arch Dis Child (1990) 1.09
Structural and functional analysis of the riboflavin synthesis genes encoding GTP cyclohydrolase II (ribA), DHBP synthase (ribBA), riboflavin synthase (ribC), and riboflavin deaminase/reductase (ribD) from Helicobacter pylori strain P1. FEMS Microbiol Lett (2000) 1.09
Elevated risk of Helicobacter pylori infection in submarine crews. Eur J Clin Microbiol Infect Dis (1992) 1.09
Characterization of lymphocytic infiltrates in Helicobacter pylori-associated gastritis. Scand J Gastroenterol (1996) 1.09
Noonan's and DiGeorge syndromes with monosomy 22q11. Arch Dis Child (1993) 1.08
Human intestinal mucosal mast cells: expanded population in untreated coeliac disease. Gut (1983) 1.08
Immunohistological evidences of cortical and medullary differentiation in thymoma. Virchows Arch A Pathol Anat Histopathol (1985) 1.07
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104. Br J Cancer (2012) 1.07
Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial. J Cancer Res Clin Oncol (2014) 1.07
Long-term consequences of Helicobacter pylori eradication: clinical aspects. Scand J Gastroenterol Suppl (1996) 1.06
Definitive diagnosis of nut allergy. Arch Dis Child (2000) 1.06
A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment Pharmacol Ther (2005) 1.06